These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 33170851)

  • 1. Use of long-acting reversible contraception among adolescents and young women in Kenya.
    Kungu W; Khasakhala A; Agwanda A
    PLoS One; 2020; 15(11):e0241506. PubMed ID: 33170851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in the use of effective and long-acting reversible contraception in Vietnam.
    Asad S; Hebert C; Andridge R; Nguyen N; Gallo MF
    Contraception; 2019 Mar; 99(3):165-169. PubMed ID: 30503505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-Acting Reversible Contraception Uptake and Associated Factors among Women of Reproductive Age in Rural Kenya.
    Ontiri S; Ndirangu G; Kabue M; Biesma R; Stekelenburg J; Ouma C
    Int J Environ Res Public Health; 2019 May; 16(9):. PubMed ID: 31052372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-acting reversible contraception in adolescents in Sub-Saharan Africa: evidence from demographic and health surveys.
    McCurdy RJ; Jiang X; Schnatz PF
    Eur J Contracept Reprod Health Care; 2018 Oct; 23(5):357-364. PubMed ID: 30465692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends and factors associated with long-acting reversible contraception in Kenya.
    Kungu W; Khasakhala A; Agwanda A
    F1000Res; 2020; 9():382. PubMed ID: 35673521
    [No Abstract]   [Full Text] [Related]  

  • 6. Predictors of choosing long-acting reversible contraceptive methods when provided free-of-charge - A prospective cohort study in Finland.
    Gyllenberg F; Saloranta T; But A; Gissler M; Heikinheimo O
    Contraception; 2020 Jun; 101(6):370-375. PubMed ID: 32061566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors associated with postpartum use of long-acting reversible contraception.
    Oduyebo T; Zapata LB; Boutot ME; Tepper NK; Curtis KM; D'Angelo DV; Marchbanks PA; Whiteman MK
    Am J Obstet Gynecol; 2019 Jul; 221(1):43.e1-43.e11. PubMed ID: 30885772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long acting reversible contraception use and associated factors among married women of reproductive age in Nepal.
    Bhandari R; Pokhrel KN; Gabrielle N; Amatya A
    PLoS One; 2019; 14(3):e0214590. PubMed ID: 30921403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Provision of long-acting reversible contraception at surgical abortion-A cross-sectional nationwide register study.
    Hogmark S; Envall N; Wikman A; Skoglund C; Kopp Kallner H; Hesselman S
    Acta Obstet Gynecol Scand; 2022 Jan; 101(1):77-83. PubMed ID: 34761384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors associated with the uptake of long-acting reversible contraception among female sex workers in post-conflict Northern Uganda: a cross-sectional study.
    Ouma S; Tumwesigye NM; Abbo C; Ndejjo R
    Reprod Health; 2022 Feb; 19(1):34. PubMed ID: 35109873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unintended pregnancy and subsequent postpartum long-acting reversible contraceptive use in Zimbabwe.
    Nance N; Ralph L; Padian N; Cowan F; Buzdugan R; Mushavi A; Mahomva A; McCoy SI
    BMC Womens Health; 2018 Nov; 18(1):193. PubMed ID: 30477497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors and the choice of long-acting reversible contraception following medical abortion: effect on subsequent induced abortion and unwanted pregnancy.
    Korjamo R; Heikinheimo O; Mentula M
    Eur J Contracept Reprod Health Care; 2018 Apr; 23(2):89-96. PubMed ID: 29537321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Rise of Female Sterilization: A Closer Look at Colombia.
    Folch BM; Betstadt S; Li D; Whaley N
    Matern Child Health J; 2017 Sep; 21(9):1772-1777. PubMed ID: 28795311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Not seeking yet trying long-acting reversible contraception: a 24-month randomized trial on continuation, unintended pregnancy and satisfaction.
    Hubacher D; Spector H; Monteith C; Chen PL
    Contraception; 2018 Jun; 97(6):524-532. PubMed ID: 29470950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-Acting Reversible Contraception Counseling and Use for Older Adolescents and Nulliparous Women.
    Gibbs SE; Rocca CH; Bednarek P; Thompson KMJ; Darney PD; Harper CC
    J Adolesc Health; 2016 Dec; 59(6):703-709. PubMed ID: 27665153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-benefit analysis of enhancing the uptake of long-acting reversible contraception in Australia.
    Concepcion K; Lacey S; McGeechan K; Estoesta J; Bateson D; Botfield J
    Aust Health Rev; 2020 Jun; 44(3):385-391. PubMed ID: 31655632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors associated with initiating long-acting reversible contraception immediately after first-trimester abortion.
    Fang NZ; Sheeder J; Teal SB
    Contraception; 2018 Oct; 98(4):292-295. PubMed ID: 29902476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contraceptive use and discontinuation among women aged 15-24 years in Kenya.
    Kungu W
    Front Reprod Health; 2023; 5():1192193. PubMed ID: 38034414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inequalities in short-acting reversible, long-acting reversible and permanent contraception use among currently married women in India.
    Das M; Anand A; Hossain B; Ansari S
    BMC Public Health; 2022 Jun; 22(1):1264. PubMed ID: 35765061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Access to long-acting reversible contraception among US publicly funded health centers.
    Bornstein M; Carter M; Zapata L; Gavin L; Moskosky S
    Contraception; 2018 May; 97(5):405-410. PubMed ID: 29253581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.